Carotid-axillary bypass as an alternative revascularization method for zone II thoracic endovascular aortic repair

Oana Bartos1, Migdat Mustafi1, Mateja Andic1

  • 1Department of Thoracic and Cardiovascular Surgery, University Medical Center Tübingen, Tübingen, Germany.

Journal of Vascular Surgery
|February 10, 2020
PubMed

Insights

Carotid-axillary bypass (CAB) offers a safe alternative for left subclavian artery revascularization during thoracic endovascular aortic repair. This method demonstrates favorable mid-term results with low complication rates, making it a viable option compared to traditional debranching procedures.

Area of Science:

  • Vascular Surgery
  • Cardiovascular Interventions
  • Aortic Disease Management

Background:

  • Thoracic endovascular aortic repair (TEVAR) often requires revascularization of the left subclavian artery (LSA).
  • Traditional debranching procedures can be associated with significant local complications.
  • Carotid-axillary bypass (CAB) has emerged as a potential alternative for LSA revascularization in zone II TEVAR.

Purpose of the Study:

  • To evaluate the mid-term clinical outcomes of carotid-axillary bypass (CAB) for left subclavian artery (LSA) revascularization in patients undergoing zone II thoracic endovascular aortic repair (TEVAR).
  • To compare the local complication rates of CAB with those of classic debranching procedures.

Main Methods:

  • Retrospective, single cohort study of 69 patients undergoing zone II TEVAR with CAB for LSA revascularization (March 2015 - December 2018).
  • Assessment of clinical outcomes including local complications, subclavian steal, arm ischemia, paraplegia, mortality, and stroke.
  • Follow-up computed tomography scans analyzed for CAB and vertebral artery (VA) patency and LSA thrombus formation.

Main Results:

  • In-hospital mortality was 3%, and perioperative stroke rate was 4%.
  • Bypass patency was 97% at a mean follow-up of 333 days; VA occlusion occurred in 6%.
  • Local complications were low, with no observed phrenic/vagus nerve lesions or chyle leakage. Arm claudication occurred in 3% due to bypass thrombosis.

Conclusions:

  • Carotid-axillary bypass (CAB) is a safe and effective alternative for LSA revascularization in zone II TEVAR.
  • CAB offers advantages in terms of reduced local complication rates compared to conventional debranching techniques.
  • The procedure demonstrates good mid-term patency and acceptable clinical outcomes.
Abstract

Related Concept Videos